References
- Lloyd-JonesDMWangTJLeipEPLifetime risk for development of atrial fibrillation the Framingham heart studyCirculation20041101042104615313941
- ZhouZQHuDYChenJZhangRHLiKBZhaoXLAn epidemiological survey of atrial fibrillation in ChinaChinese Journal of Internal Medicine200426491494 Chinese.
- QiWenhangRetrospective investigation of hospitalized patients with atrial fibrillation in mainland ChinaInt J Cardiol200510528328716274769
- NaccarelliGVVarkerHLinJSchulmanKLIncreasing prevalence of atrial fibrillation and flutter in the United StatesAm J Cardiol20091041534153919932788
- MaCSQiWHManagement of atrial fibrillation in Chinese patientsCVD Prev Control200947983
- TeoKKSedlisSPBodenWECOURAGE Trial InvestigatorsOptimal medical therapy with or without percutaneous coronary intervention in older patients with stable coronary disease: a pre-specified subset analysis of the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive druG Evaluation) trialJ Am Coll Cardiol2009541303130819778673
- LopesRDElliottLEWhiteHDAntithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trialEur Heart J2009302019202819502623
- JaneSSDavidMZhengZTrends in atrial fibrillation complicating myocardial infarctionAm J Cardiol200910416917419576341
- GageBFWatermanADShannonWBoechlerMRichMWRadfordMJValidation of clinical classification schemes for predicting stroke. Results form the National Registry of Atrial FibrillationJAMA20012852864287011401607
- AndroulakisAAznaouridisKAAggeliCJTransient ST-segment depression during paroxysms of atrial fibrillation in otherwise normal individuals: relation with underlying coronary artery diseaseJ Am Coll Cardiol2007501909191117980260
- LauDHHuynhLTChewDPAstleyCMSomanASandersPPrognostic impact of types of atrial fibrillation in acute coronary syndromesAm J Cardiol20091041317132319892044
- FumihikoKMasahitoKTaroMPhysiomics of coronary perfusion and cardiac pumpingCardiac perfusion and pumping engineeringDhanjooNGEddieYKNWashington, DCWorld Scientific Publishing Co2007115
- BilatoCCortiMCBaggioGPrevalence, functional impact, and mortality of atrial fibrillation in an older Italian population (from the Pro.V.A. Study)Am J Cardiol20091041092109719801031
- OlssonLGSwedbergKDucharmeACHARM InvestigatorsAtrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programJ Am Coll Cardiol2006471997200416697316
- HalbfassPJankoSDorwarthURiessGAntoniDHoffmannEDilemma of antithrombotic therapy in anticoagulated atrial fibrillation patients squeezed between thrombosis and bleeding events: a single-centre experienceEuropace20091195796019493910
- MaegdefesselLSchlittAFaerberJAnticoagulant and/or anti-platelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experienceMed Klin (Munich)200810362863218813885
- AndrewZFrederickFOptimizing antithrombotic strategies in patients with concomitant indications for warfarin undergoing coronary artery stentingAm J Cardiol.2009104Suppl49C54C
- Manzano-FernándezSPastorFJMarínFCambroneroFCaroCPascual-FigalDAIncreased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stentingChest200813455956718641090
- Manzano-FernándezSCaroCCambroneroFPastorFJMarínFValdés-ChavarriMAntithrombotic therapy after coronary stenting in patients with indication for oral anticoagulationInt J Cardiol200913412512718353470
- StevenFJonathanLH“Triple therapy” or triple threatJ Am Coll Cardiol20085182682718294567